Symbol="LUMO"
AssetType="Common Stock"
Name="Lumos Pharma Inc"
Description="Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of rare disease therapies. The company is headquartered in Austin, Texas."
CIK="1126234"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2503 SOUTH LOOP DRIVE, SUITE 5100, AMES, IA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="23806300"
EBITDA="-34006000"
PERatio="None"
PEGRatio="None"
BookValue="5.43"
DividendPerShare="0"
DividendYield="0"
EPS="-3.72"
RevenuePerShareTTM="0.268"
ProfitMargin="0"
OperatingMarginTTM="-15.3"
ReturnOnAssetsTTM="-0.3"
ReturnOnEquityTTM="-0.538"
RevenueTTM="2227000"
GrossProfitTTM="1523000"
DilutedEPSTTM="-3.72"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.308"
AnalystTargetPrice="17.5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="22.45"
PriceToBookRatio="0.405"
EVToRevenue="1.11"
EVToEBITDA="1.564"
Beta="0.566"
num_52WeekHigh="9.56"
num_52WeekLow="2.63"
num_50DayMovingAverage="3.307"
num_200DayMovingAverage="3.675"
SharesOutstanding="7935400"
DividendDate="2020-03-19"
ExDividendDate="None"
symbol="LUMO"
open="3.02"
high="3.02"
low="2.77"
price="2.77"
volume="2779.00"
latest_trading_day="2023-08-28"
previous_close="3.00"
change="-0.23"
change_percent="-7.6667%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="54"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="46"
Volume_recent_avg="20641"
Change_recent_avg="-0.01"
Delta_recent_avg="0.26"
Variance_recent_avg="0.13"
Change_ratio_recent_avg="-0.44"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="46"
Aroon_momentum_negative="54"
image_negative_thumbnail_id_1="1097"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0130.jpeg"
image_negative_thumbnail_id_2="1103"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0136.jpeg"
image_neutral_thumbnail_id_1="557"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0042.jpeg"
image_neutral_thumbnail_id_2="570"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0029.jpeg"
image_positive_thumbnail_id_1="609"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_positive_thumbnail_id_2="685"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0023.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1193"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0027.jpeg"
